Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Antiviral Research|September 1, 1994
Synthesis and anti-HIV activity of thiocholesteryl-coupled phosphodiester antisense oligonucleotides incorporated into immunoliposomesO Zelphati, E Wagner, L LesermanProceedings of the National Academy of Sciences of the United States of America|October 15, 1996
Mechanism of oligonucleotide release from cationic liposomesO Zelphati, F C SzokaAntisense Research and Development|January 1, 1993
Inhibition of HIV-1 replication in cultured cells with antisense oligonucleotides encapsulated in immunoliposomesO Zelphati, G Zon, L LesermanPharmaceutical Research|September 1, 1996
Intracellular distribution and mechanism of delivery of oligonucleotides mediated by cationic lipidsO Zelphati, F C SzokaExperimental Cell Research|March 1, 1991
CD4 and CD7 molecules as targets for drug delivery from antibody bearing liposomesH Suzuki, O Zelphati, G Hildebrand, et al.Human Gene Therapy|February 18, 1999
Gene chemistry: functionally and conformationally intact fluorescent plasmid DNAO Zelphati, X Liang, P Hobart, et al.Biochimica Et Biophysica Acta|May 2, 1998
Effect of serum components on the physico-chemical properties of cationic lipid/oligonucleotide complexes and on their interactions with cellsO Zelphati, L S Uyechi, L G Barron, et al.Human Gene Therapy|March 21, 1998
Analytical methods for the characterization of cationic lipid-nucleic acid complexesM E Ferrari, C M Nguyen, O Zelphati, et al.Gene Therapy|February 4, 1999
Stable and monodisperse lipoplex formulations for gene deliveryO Zelphati, C Nguyen, M Ferrari, et al.Nucleic Acids Research|October 11, 1994
Antisense oligonucleotides in solution or encapsulated in immunoliposomes inhibit replication of HIV-1 by several different mechanismsO Zelphati, J L Imbach, N Signoret, et al.Pageof 2